Photo by jareddrice from unsplash
To explore the effects of intermittent use of empagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on dietary self‐management and glycaemic control in patients with inadequately controlled type 2 diabetes. Click to show full abstract
To explore the effects of intermittent use of empagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on dietary self‐management and glycaemic control in patients with inadequately controlled type 2 diabetes.
Keywords:
management glycaemic;
dietary self;
control patients;
glycaemic control;
controlled type;
self management
Journal Title: Diabetes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!